Publications in collaboration with researchers from Hospital Universitario de Valme (1)

2024

  1. Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Glargine (Gan & Lee Glargine) Compared With Originator Insulin Glargine (Lantus) in Patients With Type 1 Diabetes After 26 Weeks Treatment

    Endocrine Practice, Vol. 30, Núm. 9, pp. 810-816